These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [The ribosome: a new player in tumorigenesis?]. Marcel V; Catez F; Mertani HC; Diaz JJ Med Sci (Paris); 2014 Jan; 30(1):21-4. PubMed ID: 24472452 [No Abstract] [Full Text] [Related]
7. Contribution of phosphoproteomics in understanding SRC signaling in normal and tumor cells. Sirvent A; Urbach S; Roche S Proteomics; 2015 Jan; 15(2-3):232-44. PubMed ID: 25403792 [TBL] [Abstract][Full Text] [Related]
8. Autophagy in arsenic carcinogenesis. Qi Y; Li H; Zhang M; Zhang T; Frank J; Chen G Exp Toxicol Pathol; 2014 Jul; 66(4):163-8. PubMed ID: 24560536 [TBL] [Abstract][Full Text] [Related]
9. Ribosomal proteins as novel players in tumorigenesis. de Las Heras-Rubio A; Perucho L; Paciucci R; Vilardell J; LLeonart ME Cancer Metastasis Rev; 2014 Mar; 33(1):115-41. PubMed ID: 24375388 [TBL] [Abstract][Full Text] [Related]
10. [Relation of micro-RNA and carcinogenesis]. Fan B; Zhang L; Ma C Zhonghua Zhong Liu Za Zhi; 2012 Jun; 34(6):401-4. PubMed ID: 22967438 [No Abstract] [Full Text] [Related]
11. Protein lysine acetylation guards metabolic homeostasis to fight against cancer. Xu W; Li Y; Liu C; Zhao S Oncogene; 2014 May; 33(18):2279-85. PubMed ID: 23665675 [TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms underlying the divergent roles of SPARC in human carcinogenesis. Nagaraju GP; Dontula R; El-Rayes BF; Lakka SS Carcinogenesis; 2014 May; 35(5):967-73. PubMed ID: 24675529 [TBL] [Abstract][Full Text] [Related]
14. miRNAs link metabolic reprogramming to oncogenesis. Hatziapostolou M; Polytarchou C; Iliopoulos D Trends Endocrinol Metab; 2013 Jul; 24(7):361-73. PubMed ID: 23602813 [TBL] [Abstract][Full Text] [Related]
15. cAMP signalling in the normal and tumorigenic pituitary gland. Formosa R; Vassallo J Mol Cell Endocrinol; 2014 Jul; 392(1-2):37-50. PubMed ID: 24845420 [TBL] [Abstract][Full Text] [Related]
16. It is well established that affected intracellular signaling is associated with carcinogenesis, cancer progression and tumor sensitivity to currently existing therapeutic approaches. Skvortsova I Semin Cancer Biol; 2015 Apr; 31():1-2. PubMed ID: 25559282 [No Abstract] [Full Text] [Related]
17. Estrogen receptor-β in mitochondria: implications for mitochondrial bioenergetics and tumorigenesis. Liao TL; Tzeng CR; Yu CL; Wang YP; Kao SH Ann N Y Acad Sci; 2015 Sep; 1350():52-60. PubMed ID: 26301952 [TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical cellular distribution of proteins related to M phase regulation in early proliferative lesions induced by tumor promotion in rat two-stage carcinogenesis models. Yafune A; Taniai E; Morita R; Akane H; Kimura M; Mitsumori K; Shibutani M Exp Toxicol Pathol; 2014 Jan; 66(1):1-11. PubMed ID: 23890812 [TBL] [Abstract][Full Text] [Related]
19. Γ-aminobutyric acid receptors affect the progression and migration of tumor cells. Zhang X; Du Z; Liu J; He J J Recept Signal Transduct Res; 2014 Dec; 34(6):431-9. PubMed ID: 25167198 [TBL] [Abstract][Full Text] [Related]
20. Inflammation, cytokines, the IL-17/IL-6/STAT3/NF-κB axis, and tumorigenesis. Chen XW; Zhou SF Drug Des Devel Ther; 2015; 9():2941-6. PubMed ID: 26089643 [No Abstract] [Full Text] [Related] [Next] [New Search]